Endo International
-
Malvern’s Endo Enters Into Agreement to Merge with Mallinckrodt in $6 Billion Deal
Malvern-based Endo has agreed to merge with Mallinckrodt in a cash and stock deal, valuing the combined pharmaceutical company at $6.7 billion, writes John George…
-
Malvern’s Endo Finds New CEO, a Former Widener College Football All-American, from Within
Endo International, the Dublin-based pharmaceutical company that has its U.S. headquarters in Malvern, has found its new CEO in Blaise Coleman. The Widener University graduate…
Founding Partners
Advertisement
Affiliate Partners
Chamber Partners
